Roles of osteoprotegerin in endocrine and metabolic disorders through receptor activator of nuclear factor kappa-B ligand/receptor activator of nuclear factor kappa-B signaling

Endocrine and metabolic diseases show increasing incidence and high treatment costs worldwide. Due to the complexity of their etiology and mechanism, therapeutic strategies are still lacking. Osteoprotegerin (OPG), a member of the tumor necrosis factor receptor superfamily, appears to be a potential...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Luodan, Zeng, Fa, Jiang, Minmin, Han, Maozhen, Huang, Binbin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671468/
https://www.ncbi.nlm.nih.gov/pubmed/36407115
http://dx.doi.org/10.3389/fcell.2022.1005681

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671468/
https://www.ncbi.nlm.nih.gov/pubmed/36407115
http://dx.doi.org/10.3389/fcell.2022.1005681

Ejemplares similares